ID
45503
Beschrijving
Principal Investigator: Geoffrey Ginsburg, MD, PhD, Institute for Genome Science and Policy, Duke University, Durham, NC, USA MeSH: Cardiovascular Diseases,Myocardial Infarction,Coronary Artery Disease https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000551 Case control cohort: The details have been previously published: American Heart Journal. 2010;160:371-379 e372. Briefly, a nested case:control cohort of CATHGEN participants who had experienced death or MI (n = 250) after their index catheterization and age-, sex-, and race-matched controls (n = 250) who were free of death/MI 2 years after cardiac catheterization was identified as part of the MURDOCK Horizon 1 Cardiovascular Disease Study.21 Sufficient RNA for microarray analysis was available in 447 members of this cohort. Observational cohort: 224 sequential CATHGEN samples were selected for whole blood RNA analysis, of which, 191 had sufficient RNA for microarray analysis.
Link
Trefwoorden
Versies (2)
- 03-11-22 03-11-22 - Simon Heim
- 13-12-22 13-12-22 - Kristina Keller
Houder van rechten
Geoffrey Ginsburg, MD, PhD, Institute for Genome Science and Policy, Duke University, Durham, NC, USA
Geüploaded op
13 december 2022
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs000551 Gene expression in CAD
Subject ID, age, sex, race, history or transplantation, days from catheterization to death, death or myocardial infraction, coronary artery disease, hyperlipidemia, hypertension, smoking, and diabetes of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Subject ID and sample ID of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Subject ID, age, sex, race, history or transplantation, days from catheterization to death, death or myocardial infraction, coronary artery disease, hyperlipidemia, hypertension, smoking, and diabetes of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Sample ID, source of biologic sample, and analyte type of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
Similar models
Subject ID, age, sex, race, history or transplantation, days from catheterization to death, death or myocardial infraction, coronary artery disease, hyperlipidemia, hypertension, smoking, and diabetes of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Subject ID and sample ID of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Subject ID, age, sex, race, history or transplantation, days from catheterization to death, death or myocardial infraction, coronary artery disease, hyperlipidemia, hypertension, smoking, and diabetes of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Sample ID, source of biologic sample, and analyte type of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
C0007430 (UMLS CUI [1,2])
C1306577 (UMLS CUI [1,3])
C0027051 (UMLS CUI [1,4])
C5239465 (UMLS CUI [1,5])
C1306577 (UMLS CUI [1,2])
C4745109 (UMLS CUI [1,3])
C0936012 (UMLS CUI [1,2])
C0332306 (UMLS CUI [1,3])
C0018823 (UMLS CUI [1,2])
C2003903 (UMLS CUI [1,2])
C1706086 (UMLS CUI [1,3])
C0947630 (UMLS CUI [1,4])